Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Johnson & Johnson
Pharma
J&J eyes earlier myeloma treatment with ph. 3 Tecvayli combo win
J&J says it plans to present the Tecvayli combo data to health authorities and disclose the detailed myeloma results at an upcoming medical meeting.
Fraiser Kansteiner
Oct 16, 2025 8:10am
J&J's Joaquin Duato 'optimistic' amid MFN discussions with Trump
Oct 14, 2025 11:52am
FDA warns of intestinal disorder risk with use of J&J's Carvykti
Oct 13, 2025 11:16am
J&J will appeal $966M award by LA jury in talcum powder lawsuit
Oct 7, 2025 3:20pm
Celltrion buy, Rexulti CRL, Glenmark-Hengrui—Fierce Pharma Asia
Sep 26, 2025 10:00am
Fujifilm Biotechnologies christens $3.2B antibody plant in NC
Sep 24, 2025 1:00pm
